FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to phthisiology, and may be used for treating patients with pulmonary tuberculosis. That is ensured by conducting the tuberculosis therapy in compliance with the standard schedules and additionally prescribing the probiotic biologically active additive SimBiovital 9.0 g in a single dose every second day with food for two months, and also the Hepel 1 tablet once a day sublingually daily for four months.
EFFECT: method provides higher clinical effectiveness in pulmonary tuberculosis as indicated by infiltration resolution, cavity closure and abacillation with reduced rate of developing adverse hepatotoxic reactions and disbiotic intestinal disorders.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH CHRONIC FORMS OF PULMONARY TUBERCULOSIS | 2013 |
|
RU2519140C1 |
METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2013 |
|
RU2521197C1 |
METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2016 |
|
RU2621875C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS | 2011 |
|
RU2452495C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS IN HIV-PATIENTS | 2008 |
|
RU2380114C1 |
METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS | 2008 |
|
RU2380113C1 |
METHOD FOR TREATMENT OF PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2007 |
|
RU2347575C1 |
THERAPY OF PULMONARY TUBERCULOSIS | 2008 |
|
RU2364428C1 |
METHOD FOR TREATMENT OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2015 |
|
RU2611391C1 |
METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2012 |
|
RU2491077C1 |
Authors
Dates
2012-07-20—Published
2011-04-06—Filed